More
    Guided Solutions - Connecting Talent With Innovation/div>

    Monthly Archives: January, 2021

    Neurolief and Sawai Enter into Exclusive Development and Marketing Agreement for Relivion®

    Neurolief Ltd., a neurotechnology innovator, announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development...

    A 40-year Battle against Racism and Health Inequities

    Paul Underwood, M.D., medical director at Boston Scientific, looks like a kindly college professor. But beneath his unassuming...

    Abbott receives CE mark for COVID-19 asymptomatic testing and self-swabbing

    Abbott has received the CE mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the...

    Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities

    Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered into an agreement...

    DarioHealth moves into back pain with $31M acquisition

    Digital health startup DarioHealth bought musculoskeletal startup Upright for $31 million. The company makes adhesive devices users can stick to their back...

    Computing firm introduces a new range of surgical monitors

    Computing firm ADLINK Technology has introduced the ASM (ADLINK Surgical Monitor) series of surgical monitors, which are designed for integration with endoscopic,...

    Allurion Technologies Launches Healthcare Software Suite That Will Transform Consumer and Provider Experience

     Allurion ® Technologies , a Leading Company Pioneering the Development of Innovative, Scalable and Reliable Weight Loss Experiences, Announced a Major Breakthrough which enhances weight loss program...

    Edinburgh firm closes £1.2m funding round for neuromotor pen

    Edinburgh medtech company Manus Neurodynamica has closed a £1.2 million funding round to support the launch of its digital pen which provides...

    Surmodics drug-coated balloon on par with Medtronic’s in study

    Surmodics' drug-coated balloon to treat peripheral artery disease was found to be non-inferior to Medtronic's market-leading IN.PACT Admiral device, meeting primary endpoints...

    Aktiia receives CE mark for 24/7 blood pressure monitoring system

    Aktiia has received a CE mark for its automated blood pressure monitoring system, which the company says is the first of its...

    OrthoSpin Gains FDA Clearance for G2 System

    OrthoSpin was granted FDA 510(k) clearance to market a next-generation robotic digitally-enabled external fixation system. The...

    Kardium Announces $115M in New Financing for Innovative Atrial Fibrillation Treatment

    Fidelity Management & Research Company LLC and T. Rowe Price funds lead private financing round Kardium Inc., developer...

    Archives

    Latest articles

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.
    59.5k Followers
    Follow